Caterpillar posted its first $20 billion quarter in company history, with sales and revenues reaching $20.5 billion, up 24% year-over-year and handily beating Wall Street's consensus estimate of approximately $19.3 billion. Adjusted earnings per share surged 73% to $8.17, far exceeding the analyst consensus of roughly $6.19–$6.25 per share, while GAAP (Generally Accepted Accounting Principles) EPS climbed to $7.77 from $4.62 a year ago.

Revenue reached a record $11.54 billion , up 50% year-over-year and ahead of the $11.28 billion consensus estimate. Non-GAAP earnings per share came in at $1.66 , exceeding Wall Street's $1.62 forecast and reflecting an 82% comparable increase from the prior year.

Xenon Pharmaceuticals shares traded at $64.01 as of early August 2026, reflecting a modest gain of approximately 5.7% over the trailing 30-day period. The company's lead asset, azetukalner, delivered highly positive Phase 3 X-TOLE2 data in focal onset seizures and management expects to submit a New Drug Application to the FDA in the third quarter of 2026.

Scholar Rock (SRRK) shares fell approximately 13.7% over the last 30 days, declining from $55.36 on July 6, 2026, to $47.79 as of August 4, 2026. The primary catalyst behind the sell-off was an announcement on July 20 that the European Medicines Agency's (EMA) CHMP opinion on apitegromab hinges on the FDA's classification of the Catalent Indiana manufacturing facility, introducing fresh regulatory uncertainty.

MOVE shares closed at $13.73 on Tuesday, up +27.60% from the prior session's close of $10.76, after spiking as much as +112% in pre-market trading and opening at $18.78 before pulling back during the regular session. The primary catalyst: Corvex announced a multi-year agreement to supply clusters of NVIDIA Blackwell GPUs with Quantum-2 InfiniBand networking to a leading, unnamed AI company, expanding an existing customer commitment.

BRKR closed at $50.30, plunging -21.79% during the regular trading session following the release of Q2 2026 earnings. The primary catalyst was a revenue miss: Q2 revenue of $838.5M fell short of the $853.39M analyst consensus, and the company lowered its full-year FY2026 revenue guidance midpoint to $3.56B from $3.59B, also below Street estimates.

CERT closed at $7.80 on Tuesday, down -4.65% from $8.18, after an extreme intraday swing from a low of $6.33 to a high of $7.83 on heavy volume of 10.8M shares. The move followed a steep premarket gap down of nearly -19% after Q2 2026 earnings were released before the open, with the stock recovering substantially during the regular session.

REZI closed at $26.17 on Tuesday, plunging -27.77% ($10.06) from its previous close of $36.23, with the entire move occurring during regular trading hours. The decline is a mechanical price adjustment following the completion of the ADI Global Distribution spin-off, with ADI beginning independent trading on the NYSE under ticker ADIG on August 4.

Element Solutions shares have declined approximately 8% over the past 30 days as the initial merger premium from the Solstice Advanced Materials acquisition announcement continues to erode. The $14.5 billion cash-and-stock buyout, announced July 6, valued ESI at roughly $50.10 per share — a level the stock has since drifted significantly below amid shareholder dissatisfaction on both sides.

AHCO plunged -38.13% during Tuesday's regular session, closing at $6.70 after reporting Q2 2026 results that severely missed expectations across all key metrics. The primary catalyst was a disastrous Q2 earnings report: adjusted EPS of -$0.99 versus consensus of +$0.15, and revenue of $740.3M missing the $848.9M estimate.

Price target in focus: $60 per share — a level that would represent a new all-time high and roughly 33% upside from the latest closing price near $45. Strongest bullish factors: Robust revenue growth, a low P/E ratio of approximately 11, an asset-light B2B marketplace model, accelerating international expansion, and active share buybacks.

GigaCloud Technology (GCT) shares surged approximately 39% between early July and early August 2026, climbing from $33.21 to $46.23. Over the broader quarter, the stock followed a volatile path — falling sharply after its Q1 2026 earnings beat in early May, bottoming near $31.50 in June, then staging a powerful recovery.

VERX plunged -13.73% during regular trading on Tuesday, extending a pre-market decline of roughly -2% after the company's Q2 2026 results sparked a sharp selloff. The Q2 earnings and revenue beat consensus ($0.20 EPS vs. $0.19; $203.97M vs. $202.30M), but Q3 revenue guidance of $208M–$211M missed the $211.70M Street estimate, rattling investors.

UL Solutions shares plunged -14.71% to $77.66 during regular trading after reporting Q2 2026 results that beat estimates but sparked deepening investor concerns throughout the session. Q2 earnings beat handily — adjusted EPS of $0.59 vs. $0.51 consensus — and revenue rose +5.2% YoY to $816 million with record adjusted EBITDA margin of 26.8%, yet the stock sold off sharply.

AIN plunged approximately -14.6% during regular trading hours, falling from a prior close of $75.12 to around $64.17 after reporting Q2 2026 earnings. The company posted Q2 adjusted EPS of $0.82, beating the $0.74 consensus, but revenue of $329.5 million missed estimates of $342.5 million, triggering the selloff.

Centuri Holdings shares plunged -17.44% during regular trading on Tuesday following the release of Q2 2026 results, with the stock dropping from a prior close of $27.86 to approximately $23.00. The decline came despite record quarterly revenue of $962 million (+33% YoY), as investors focused on deteriorating profitability metrics including a 2% rise in gross profit that sharply lagged revenue growth.

REZI shares dropped -24.95% to $27.19 during regular market trading on August 4, 2026, following the completed spin-off of its ADI Global Distribution unit. The decline is a mechanical corporate-action adjustment: REZI distributed one ADI share for every two REZI shares held, and ADI began trading independently today on the NYSE under ticker "ADIG."

AHCO shares plunged approximately -41.50% during regular trading after the company reported Q2 2026 results that missed consensus estimates across all key metrics. The company posted a GAAP loss of -$0.99 per share, dramatically below the analyst consensus of +$0.15 profit, driven largely by a $144.2 million non-cash goodwill impairment charge.

CBT plunged -11.23% during Tuesday's regular session, extending a -4.58% premarket decline after reporting Q3 fiscal 2026 results that beat on adjusted EPS ($1.67 vs. $1.65 consensus) and revenue ($982M vs. $943M expected) but revealed deep cracks beneath the surface. GAAP net income collapsed to $6M ($0.12/share) from $101M ($1.86/share) a year ago, weighed down by $78M in restructuring charges and one-time costs that spooked investors despite the headline adjusted earnings beat.

BRKR shares plunged -18.02% to $52.72 during regular trading after reporting Q2 2026 results before the open, erasing recent gains from a prior close of $64.31. The primary catalyst was a top-and-bottom-line miss: revenue of $838.5M fell -1.9% short of the $854.8M consensus, and full-year revenue guidance was cut to $3.56B at the midpoint from $3.59B.